Centers for Disease Control and Prevention - ERA

Description

The NCIRD, Division of Viral Diseases, Epidemiology Branch is projecting to host a 5-year, competitive cooperative agreement starting in FY2016 and having a period of performance lasting September 1, 2016 – August 31, 2021. This cooperative agreement will fund a network of pediatric medical institutions conducting prospective, active surveillance for acute gastroenteritis (AGE) and acute respiratory illnesses (ARI) in inpatient and emergency department clinical settings, and among healthy controls. Funded activities will provide a principal US pediatric vaccine-preventable (and potentially vaccine preventable) disease surveillance system, to include actively assessing a wide spectrum of AGE, ARI and influenza pathogens, evaluations of vaccine effectiveness for licensed vaccines, burden and natural history of disease for pathogens having upcoming and/or new vaccines, pediatric infectious disease transmission dynamics, vaccination/therapeutic policy and development, vaccine impacts for targeted and vulnerable populations, and socioeconomic and microbiological environments potentially relevant to these public health interventions.

Who can apply

• State governments
• County governments
• City or township governments
• Special district governments
• Independent school districts
• Public and State controlled institutions of higher education
• Native American tribal governments (Federally recognized)
• Public housing authorities / Indian housing authorities
• Native American tribal organizations (other than Federally recognized)
• Nonprofits with 501(c)(3) status (other than higher education)
• Nonprofits without 501(c)(3) status (other than higher education)
• Private institutions of higher education
• Others

Contact

Deborah Loveys<br/>hft6@cdc.gov<br/>
hft6@cdc.gov